Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferri

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
International Journal of Cardiology|February 11, 2023
Corrigendum to "Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial" [Int J Cardiol. 2022 Dec 15;369:5-11]G De Luca, M Verdoia, N Morici, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 22, 2020
Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational studyFrancesco Giannini, Matteo Pagnesi, Gianluca Campo, et al.
Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.
JACC. Advances|June 30, 2026
Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG RegistryCarlo Gaspardone, Daniela Trabattoni, Daniele O d'Atri, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
International Journal of Cardiology|February 11, 2023
Corrigendum to "Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial" [Int J Cardiol. 2022 Dec 15;369:5-11]G De Luca, M Verdoia, N Morici, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 22, 2020
Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational studyFrancesco Giannini, Matteo Pagnesi, Gianluca Campo, et al.
Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.
JACC. Advances|June 30, 2026
Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG RegistryCarlo Gaspardone, Daniela Trabattoni, Daniele O d'Atri, et al.
Pageof 17